Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119


New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney.

Zaravinos A, Lambrou GI, Mourmouras N, Katafygiotis P, Papagregoriou G, Giannikou K, Delakas D, Deltas C.

PLoS One. 2014 Mar 12;9(3):e91646. doi: 10.1371/journal.pone.0091646. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100063.


MicroRNA profiles classify papillary renal cell carcinoma subtypes.

Wach S, Nolte E, Theil A, Stöhr C, T Rau T, Hartmann A, Ekici A, Keck B, Taubert H, Wullich B.

Br J Cancer. 2013 Aug 6;109(3):714-22. doi: 10.1038/bjc.2013.313. Epub 2013 Jun 25.


Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Wotschofsky Z, Gummlich L, Liep J, Stephan C, Kilic E, Jung K, Billaud JN, Meyer HA.

PLoS One. 2016 Feb 9;11(2):e0148746. doi: 10.1371/journal.pone.0148746. eCollection 2016.


MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.


MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.

He H, Wang L, Zhou W, Zhang Z, Wang L, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X, Ge J.

PLoS One. 2015 May 4;10(5):e0125672. doi: 10.1371/journal.pone.0125672. eCollection 2015.


MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Biol Ther. 2014 Mar 1;15(3):329-41. doi: 10.4161/cbt.27314. Epub 2013 Dec 18.


MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O.

Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13.


Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.

Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM.

Clin Biochem. 2010 Jan;43(1-2):150-8. doi: 10.1016/j.clinbiochem.2009.07.020. Epub 2009 Jul 29.


Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.


Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O.

J Transl Med. 2012 Mar 22;10:55. doi: 10.1186/1479-5876-10-55.


Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.

Müller S, Nowak K.

Biomed Res Int. 2014;2014:948408. doi: 10.1155/2014/948408. Epub 2014 May 22.


Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.

Wotschofsky Z, Liep J, Meyer HA, Jung M, Wagner I, Disch AC, Schaser KD, Melcher I, Kilic E, Busch J, Weikert S, Miller K, Erbersdobler A, Mollenkopf HJ, Jung K.

Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106. Epub 2012 Oct 28.


miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.

White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM.

Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27.


Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.

Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, van Poppel H.

PLoS One. 2012;7(6):e38298. doi: 10.1371/journal.pone.0038298. Epub 2012 Jun 20.


Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.

Nakata W, Uemura M, Sato M, Fujita K, Jingushi K, Ueda Y, Kitae K, Tsujikawa K, Nonomura N.

Oncotarget. 2015 Aug 28;6(25):21645-54.


Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.

Yamada Y, Hidaka H, Seki N, Yoshino H, Yamasaki T, Itesako T, Nakagawa M, Enokida H.

Cancer Sci. 2013 Mar;104(3):304-12. doi: 10.1111/cas.12072. Epub 2012 Dec 29.


Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.

Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R.

Genes Chromosomes Cancer. 2012 Jul;51(7):707-16. doi: 10.1002/gcc.21957. Epub 2012 Apr 10.


Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.

Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.

J Pathol. 2008 Dec;216(4):418-27. doi: 10.1002/path.2437.


miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.

White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Yousef GM.

J Urol. 2011 Sep;186(3):1077-83. doi: 10.1016/j.juro.2011.04.110. Epub 2011 Jul 23.


Supplemental Content

Support Center